141 related articles for article (PubMed ID: 2746048)
1. Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Int J Pancreatol; 1989 Jul; 5(1):85-98. PubMed ID: 2746048
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Virchows Arch A Pathol Anat Histopathol; 1989; 414(6):465-76. PubMed ID: 2499104
[TBL] [Abstract][Full Text] [Related]
3. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Br J Cancer; 1986 Feb; 53(2):189-95. PubMed ID: 3513813
[TBL] [Abstract][Full Text] [Related]
5. Lex and Ley antigen expression in human pancreatic cancer.
Kim YS; Itzkowitz SH; Yuan M; Chung Y; Satake K; Umeyama K; Hakomori S
Cancer Res; 1988 Jan; 48(2):475-82. PubMed ID: 3335015
[TBL] [Abstract][Full Text] [Related]
6. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Int J Cancer; 1986 Dec; 38(6):841-6. PubMed ID: 3466871
[TBL] [Abstract][Full Text] [Related]
7. The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.
Makovitzky J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):535-44. PubMed ID: 2878526
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry of CEA in the human pancreas during development, in the adult, chronic pancreatitis, and pancreatic adenocarcinoma.
Albers GH; Fleuren G; Escribano MJ; Nap M
Am J Clin Pathol; 1988 Jul; 90(1):17-22. PubMed ID: 3389342
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies on the expression of gastrointestinal-cancer-associated antigen, PA8-15, CA19-9 and the blood-group antigens in non-malignant and malignant human pancreatic tissues.
Egami H; Sakamoto K; Yoshimura R; Arai M; Takiyama Y; Pour PM
J Cancer Res Clin Oncol; 1990; 116(4):365-71. PubMed ID: 2391357
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on the expression of the blood group antigens Le(a), Le(b), Le(x), Le(y) and the carbohydrate antigens CA19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Makovitzky J; Schwenk J
Acta Histochem Suppl; 1990; 40():143-6. PubMed ID: 2091042
[No Abstract] [Full Text] [Related]
11. Serum levels of CA 19-9 and CA 50 in relation to Lewis blood cell status in patients with malignant and benign pancreatic disease.
von Rosen A; Linder S; Harmenberg U; Pegert S
Pancreas; 1993 Mar; 8(2):160-5. PubMed ID: 8460090
[TBL] [Abstract][Full Text] [Related]
12. Expression of CA125 in pancreatic carcinoma and chronic pancreatitis.
Macdonald F; Downing R; Allum WH
Br J Cancer; 1988 Oct; 58(4):505-6. PubMed ID: 3207606
[No Abstract] [Full Text] [Related]
13. Expression of blood group-related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein.
Ichihara T; Sakamoto J; Nakao A; Furukawa K; Watanabe T; Suzuki N; Horisawa M; Nagura H; Lloyd KO; Takagi H
Cancer; 1993 Jan; 71(1):71-81. PubMed ID: 8416729
[TBL] [Abstract][Full Text] [Related]
14. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis.
Malesci A; Tommasini MA; Bonato C; Bocchia P; Bersani M; Zerbi A; Beretta E; Di Carlo V
Gastroenterology; 1987 Jan; 92(1):60-7. PubMed ID: 3465666
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated alterations of blood group antigen expression in the human pancreas.
Itzkowitz SH; Yuan M; Ferrell LD; Ratcliffe RM; Chung YS; Satake K; Umeyama K; Jones RT; Kim YS
J Natl Cancer Inst; 1987 Sep; 79(3):425-34. PubMed ID: 2442445
[TBL] [Abstract][Full Text] [Related]
16. The occurrence of carbohydrate antigens (CA 19-9, CA-50) in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Acta Histochem Suppl; 1990; 38():183-7. PubMed ID: 2080240
[No Abstract] [Full Text] [Related]
17. Immuno-histochemical investigations with monoclonal antibodies against CEA-related components in chronic pancreatitis and pancreatic carcinoma.
Makovitzky J
Hepatogastroenterology; 1987 Feb; 34(1):31-5. PubMed ID: 2437000
[TBL] [Abstract][Full Text] [Related]
18. Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray based study.
Nash JW; Bhardwaj A; Wen P; Frankel WL
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):59-63. PubMed ID: 17536309
[TBL] [Abstract][Full Text] [Related]
19. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.
Yantiss RK; Woda BA; Fanger GR; Kalos M; Whalen GF; Tada H; Andersen DK; Rock KL; Dresser K
Am J Surg Pathol; 2005 Feb; 29(2):188-95. PubMed ID: 15644775
[TBL] [Abstract][Full Text] [Related]
20. [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].
Larena A; Vierbuchen M; Schröder S; Larena-Avellaneda A; Hadshiew I; Fischer R
Langenbecks Arch Chir; 1996; 381(2):102-13. PubMed ID: 8649124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
